ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Glaxosmithkline Puerto Rico, INC.

Official 2024 U.S. DOL Form 5500 summary for Glaxosmithkline Puerto Rico, INC. (Gsk Puerto Rico 401(k) Plan · EIN 66-0613421 · PN 002): $57.08M net assets, 16 active participants, and $0.75 per $10,000 (0.75 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorGlaxosmithkline Puerto Rico, INC.
Filing IdentifierGsk Puerto Rico 401(k) Plan · EIN 66-0613421 · PN 002
Plan Category & StateESOP & Profit-Sharing DC (PA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$57.08M
Active Participants16
Direct Admin Fee Rate$0.75 per $10,000 (0.75 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderState Street Global Advisors
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for GSK across sibling Meru AI platforms.